Clinical Trial

A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2025 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prediction of preoperative endometrial biopsy: the evolution from hyperplasia to cancer, the prognosis and the risk of recurrence. Intelligence methods artificial risk will be used to redefine the current risk classes including our profile immuno-mutational to provide a more precise characterization and closer to the real prognosis of the patient.
Trial Details
NCT Number NCT06841653
Lead Sponsor Regina Elena Cancer Institute
Collaborators: University of Rome Tor Vergata, IRCCS Casa Sollievo della Sofferenza, Universita degli Studi di Palermo
Conditions Endometrium Cancer
Enrollment 40 participants
Start Date 2024-06-20
Primary Completion 2026-06-20 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2025-02-24